{"id":8313,"date":"2013-08-07T13:59:19","date_gmt":"2013-08-07T13:59:19","guid":{"rendered":""},"modified":"2016-03-25T08:49:19","modified_gmt":"2016-03-25T08:49:19","slug":"vaiku-viduriavimas-naujas-sprendimo-budas","status":"publish","type":"post","link":"https:\/\/www.pasveik.lt\/lt\/naujausi-medicinos-straipsniai\/vaiku-viduriavimas-naujas-sprendimo-budas\/8313\/","title":{"rendered":"Vaik\u0173 viduriavimas: naujas sprendimo b\u016bdas"},"content":{"rendered":"<p><!-- [if !mso]>\n\n\n<style>\nv\\:* {behavior:url(#default#VML);}\no\\:* {behavior:url(#default#VML);}\nw\\:* {behavior:url(#default#VML);}\n.shape {behavior:url(#default#VML);}\n<\/style>\n\n\n<![endif]--><\/p>\n<p style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\"><!-- [if gte mso 9]><xml>\n <o:OfficeDocumentSettings>\n  <o:AllowPNG\/>\n  <o:TargetScreenSize>1024x768<\/o:TargetScreenSize>\n <\/o:OfficeDocumentSettings>\n<\/xml><![endif]--><!-- [if gte mso 9]><xml>\n <w:WordDocument>\n  <w:View>Normal<\/w:View>\n  <w:Zoom>0<\/w:Zoom>\n  <w:HyphenationZone>19<\/w:HyphenationZone>\n  <w:Compatibility>\n   <w:BreakWrappedTables\/>\n   <w:SnapToGridInCell\/>\n   <w:WrapTextWithPunct\/>\n   <w:UseAsianBreakRules\/>\n  <\/w:Compatibility>\n <\/w:WordDocument>\n<\/xml><![endif]--><!-- [if gte mso 10]>\n\n\n<style>\n \/* Style Definitions *\/\n table.MsoNormalTable\n\t{mso-style-name:\"Table Normal\";\n\tmso-tstyle-rowband-size:0;\n\tmso-tstyle-colband-size:0;\n\tmso-style-noshow:yes;\n\tmso-style-parent:\"\";\n\tmso-padding-alt:0cm 5.4pt 0cm 5.4pt;\n\tmso-para-margin:0cm;\n\tmso-para-margin-bottom:.0001pt;\n\tmso-pagination:widow-orphan;\n\tfont-size:10.0pt;\n\tfont-family:\"Times New Roman\";}\n<\/style>\n\n\n<![endif]--><!-- [if gte mso 9]><xml>\n <o:shapedefaults v:ext=\"edit\" spidmax=\"1029\"\/>\n<\/xml><![endif]--><!-- [if gte mso 9]><xml>\n <o:shapelayout v:ext=\"edit\">\n  <o:idmap v:ext=\"edit\" data=\"1\"\/>\n <\/o:shapelayout><\/xml><![endif]--><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold;\">Viduriavimo problema i\u0161lieka aktuali visame pasaulyje. Tai ypa\u010d svarbu pediatrijoje, nes ma\u017eame\u010diams ne tik da\u017eniau b\u016bdingas <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/viduriavimas-2\/72707\">viduriavimas<\/a>, bet ir neretos jo sukeltos komplikacijos. Manoma, kad visi vaikai per pirmuosius trejus metus yra bent kart\u0105 viduriav\u0119. Daugelyje Europos \u0161ali\u0173 <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/viduriavimas-2\/72707\">viduriavimas<\/a> paprastai yra lengva liga, ta\u010diau ji susijusi su dideliu hospitalizacij\u0173 bei nemenku mir\u010di\u0173 skai\u010diumi. Tai, be abejo, priklauso nuo viduriavimo trukm\u0117s ir jo sukelt\u0173 komplikacij\u0173, toki\u0173 kaip dehidratacija ar drusk\u0173 netekimas, o viduriavimo da\u017enis populiacijoje neatsiejamas nuo \u0161alies tradicij\u0173, kult\u016bros ir sveikatos apsaugos lygio.<\/span><\/em><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Viduriavimu vadinamas tu\u0161tinimasis da\u017eniau nei tris kartus per par\u0105 skystomis, kartais vandeningomis, su gleivi\u0173 ar kraujo priemai\u0161a i\u0161matomis. \u017dindomi k\u016bdikiai normaliai gali tu\u0161tintis 5\u20136 kartus, vyresni 1\u20132 kartus per dien\u0105.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><a name=\"priezastys-ir-rizikos-veiksniai\"><\/a><strong><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Ligos prie\u017eastys ir rizikos veiksniai<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Viduriavimai pagal prie\u017eastis skiriami \u012f dvi stambias grupes: infekciniai ir neinfekciniai. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold;\">Infekcin\u0117s kilm\u0117s viduriavim\u0105 gali sukelti:<\/span><\/em><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l3 level1 lfo5;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">virusai (da\u017eniausiai rotavirusai, ypa\u010d \u017eiemos metu);<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l3 level1 lfo5;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">bakterijos (salmonel\u0117s, \u0161igel\u0117s, kampilobakterijos, jersinijos, e\u0161erichijos \u2013 da\u017eniau vasar\u0105);<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l3 level1 lfo5;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">pirmuonys (lamblijos, kriptosporidijos);<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l3 level1 lfo5;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">kirminai (askarid\u0117s).<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold;\">Neinfekcinio viduriavimo prie\u017eastimi gali b\u016bti:<\/span><\/em><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">celiakija (\u017earnyno nepakantumas kai kuri\u0173 gr\u016bd\u0173 baltymams);<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">disbakterioz\u0117 (atsirandanti d\u0117l ilgo ar da\u017eno antibiotik\u0173 vartojimo);<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">alergin\u0117 enteropatija;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">permaitinimas arba netinkamas maistas;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">dant\u0173 kalimasis;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">susijaudinimas, baim\u0117, nervin\u0117 \u012ftampa (vyresniems vaikams).<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><a name=\"simptomai-ir-pozymiai\"><\/a><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"mso-bookmark: simptomai-ir-pozymiai;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-style: italic;\">Ligos simptomai ir po\u017eymiai<\/span><\/strong><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Viduriuojantis vaikas tampa irzlus, neramus, netenka apetito, gali vemti, kar\u0161\u010diuoti. Atsiranda dehidratacijos (skys\u010di\u0173 netekimo) simptomai: tro\u0161kulys, sausos gleivin\u0117s, bly\u0161ki oda su pilk\u0161vu atspalviu, pada\u017en\u0117j\u0119s kv\u0117pavimas, retas, negausus \u0161lapinimasis, k\u016bdikiams \u2013 \u012fdub\u0119s momen\u0117lis. Viduriavimo pob\u016bdis priklauso nuo j\u012f suk\u0117lusios prie\u017easties: esant virusin\u0117s kilm\u0117s ligai, viduriuojama iki 10 kart\u0173 per par\u0105, i\u0161matos gausios, vandeningos, r\u016bg\u0161taus kvapo; bakteriniam viduriavimui b\u016bdingas labai da\u017enas \u2013 10\u201315 kart\u0173 per dien\u0105 tu\u0161tinimasis, paprastai negausiomis, skystomis, puv\u0117si\u0173 kvapo i\u0161matomis, kuriose gali b\u016bti gleivi\u0173, p\u016bli\u0173 ar kraujo; sergant celiakija, ligonis tu\u0161tinasi 1\u20133 kartus per par\u0105 labai gausiomis, bly\u0161kiomis, blizgan\u010diomis, dvokian\u010diomis, skystos konsistencijos i\u0161matomis. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Gydytojas viduriavim\u0105 diagnozuoja i\u0161siai\u0161kin\u0119s tu\u0161tinimosi da\u017en\u012f, i\u0161mat\u0173 pob\u016bd\u012f. Prie\u017eas\u010diai nustatyti atliekamas kraujo tyrimas, tiriamos i\u0161matos (nustatomas rotaviruso antigenas, daromas bakteriologinis pas\u0117lis, mikroskopu ie\u0161koma pirmuoni\u0173, kirmin\u0173).<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Vienas da\u017eniausi\u0173 diar\u0117jos kaltinink\u0173 \u2013 rotavirusin\u0117 infekcija<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\"><a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/roto-virusas\/72688\">Rotavirusin\u0117 infekcija<\/a>\u00a0\u2013 \u016bmin\u0117 rotavirus\u0173 sukelta \u017earnyno infekcija, pasirei\u0161kianti bendra organizmo intoksikacija, skrand\u017eio ir plonosios \u017earnos u\u017edegimu, neretai, ypa\u010d vaikams, b\u016bna lengv\u0173 vir\u0161utini\u0173 kv\u0117pavimo tak\u0173 katarini\u0173 rei\u0161kini\u0173 (<a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/sloga\/56472\">sloga<\/a>, \u010diaudulys, gerkl\u0117s paraudimas, nedidelis jos skausmas).<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Rotavirusas \u2013 tai rato formos virusas, kuris labai atsparus aplinkos veiksniams, \u012fvairioms dezinfekcin\u0117ms med\u017eiagoms, gali ilgai i\u0161likti aplinkoje. Esant 4\u201320 laipsni\u0173 temperat\u016brai, jis i\u0161lieka gyvybingas kelis m\u0117nesius. Rotavirusai yra gana atspar\u016bs buityje naudojamiems lengvo poveikio plovikliams, ta\u010diau greitai \u017e\u016bsta veikiami chloro turin\u010diomis dezinfekuojan\u010diomis med\u017eiagomis, virinant. Rotavirus\u0173 b\u016bna upi\u0173, e\u017eer\u0173, j\u016br\u0173 vandenyje, taip pat po\u017eeminiuose bei vandentiekio vandenyse. Rotavirusai labai dideliais kiekiais i\u0161skiriami su sergan\u010diojo i\u0161matomis, o tam, kad u\u017esikr\u0117stume, pakanka tik 10 viruso daleli\u0173. Virusas i\u0161skiriamas \u016bmiu ligos periodu, vidutini\u0161kai 4\u20136 dienas. Tod\u0117l rotavirus\u0173 atsparumas i\u0161orin\u0117je aplinkoje ir labai ma\u017ea u\u017ekre\u010diamoji doz\u0117 sudaro prielaidas pla\u010diam j\u0173 paplitimui visuomen\u0117je.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Did\u017eiausias infekcijos \u0161altinis yra sergantis vaikas ir viruso ne\u0161iotojai, kurie serga simptom\u0173 nesukelian\u010dia forma. Nuo gyv\u016bn\u0173 \u0161ia infekcija neu\u017esikre\u010diama, nes tarp j\u0173 cirkuliuojantys virusai vaikui nepavojingi. Rotavirusais u\u017esikre\u010diama per burn\u0105, nes infekcija plinta per ne\u0161varias rankas ir u\u017eter\u0161t\u0105 aplink\u0105. Kadangi virusai ilg\u0105 laik\u0105 gali i\u0161likti gyvybingi aplinkoje, jie gali plisti per \u012fvairius daiktus, kuriuos vaikai gali \u012fsid\u0117ti \u012f burn\u0105. Manoma, kad <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/roto-virusas\/72688\">rotavirusine infekcija<\/a>\u00a0galima u\u017esikr\u0117sti ir per kv\u0117pavimo takus kaip gripu ar kitomis \u016bmin\u0117mis kv\u0117pavimo tak\u0173 infekcijomis. \u0160ia liga galima susirgti ir u\u017esikr\u0117tus nuo maisto, jei jis buvo gamintas ne\u0161variomis rankomis. Ta\u010diau tai da\u017eniausiai maistas, vartojamas be papildomo apdorojimo \u0161iluma, pavyzd\u017eiui, sumu\u0161tiniai, mi\u0161rain\u0117s. Yra \u012frodym\u0173, kad infekcija gali plisti ir per vanden\u012f. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Vaik\u0173 kolektyvuose (dar\u017eeliuose, mokyklose) vaikai da\u017eniausiai u\u017esikre\u010dia vienas nuo kito. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">K\u016bdikiai, maitinami motinos pienu, pasidaro atspar\u016bs \u0161iai ligai, tod\u0117l b\u016bdingi ligos simptomai gali nepasireik\u0161ti, ta\u010diau jie su i\u0161matomis \u012f aplink\u0105 i\u0161skiria virus\u0105 dideliais kiekiais. Jei toki\u0173 ligoni\u0173 yra vaik\u0173 gydymo \u012fstaigose, gali kilti pavojus nei\u0161ne\u0161iotiems ir silpniems k\u016bdikiams bei vyresniems vaikams. Tais atvejais <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/roto-virusas\/72688\">rotavirusin\u0117 infekcija<\/a>\u00a0pasirei\u0161kia kaip <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/hospitaline-infekcija\/43825\">hospitalin\u0117 infekcija<\/a>.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Rotavirusinei infekcijai b\u016bdingas sezoni\u0161kumas. Ji, kaip ir <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/gripas\/4328\">gripas<\/a>, da\u017eniausiai pasirei\u0161kia \u0161altuoju met\u0173 laiku \u2013 lapkri\u010dio\u2013baland\u017eio m\u0117nesiais, nes abiej\u0173 \u0161i\u0173 lig\u0173 virusai geriau i\u0161silaiko \u0161altyje. Persirgus \u0161ia liga imunitetas susidaro tik laikinai, o ma\u017ei vaikai asmenin\u0117s higienos \u012fg\u016bd\u017ei\u0173 neturi, tod\u0117l u\u017esikr\u0117sti ir susirgti <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/roto-virusas\/72688\">rotavirusine infekcija<\/a>\u00a0jie gali kelet\u0105 kart\u0173.<span style=\"mso-spacerun: yes;\">\u00a0 <\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Daugyb\u0117 \u017emoni\u0173 gali b\u016bti \u0161io viruso ne\u0161iotojai, tod\u0117l labai svarbu slaugant sergant\u012f vaik\u0105 kuo da\u017eniau plauti rankas.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-style: italic;\">K\u0105 patarti, jei sergan\u010diojo mama kreip\u0117si konsultacijos \u012f vaistinink\u0105<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold;\">Rekomenduojama patarti:<\/span><\/em><\/p>\n<ul style=\"margin-top: 0cm;\">\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l4 level1 lfo3; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Duoti vaikui gerti skys\u010di\u0173. Skys\u010di\u0173 praradimas ypa\u010d pavojingas k\u016bdikiams ir ma\u017eiems vaikams; jiems prarast\u0105 skyst\u012f gali tekti kompensuoti la\u0161ine skys\u010di\u0173 infuzija (ligonin\u0117je). Skys\u010dius reikia girdyti nedideliais kiekiais, geriausia po 5\u201310 ml kas 2\u20133 minutes. Jeigu k\u016bdikis atsisako gerti, reik\u0117t\u0173 girdyti arbatiniu \u0161auk\u0161teliu ar pipete la\u0161inant skys\u010dius \u012f burn\u0105.<\/span><\/li>\n<\/ul>\n<ul style=\"margin-top: 0cm;\">\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Lengvoms viduriavim\u0173 formoms gali b\u016bti taikoma dieta. Gerti tik nesaldint\u0105 arbat\u0105 (ramun\u0117li\u0173, \u0105\u017euol\u0173 \u017eiev\u0117s, m\u0117lyni\u0173, gervuogi\u0173). Viduriavimui susilpn\u0117jus, su arbata galima prad\u0117ti valgyti d\u017ei\u016bv\u0117sius, avi\u017e\u0173 kisieli\u0173, keptus obuolius ir bananus \u2013 tok\u012f maist\u0105 valgantis vaikas v\u0117l pradeda normaliai tu\u0161tintis.<\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Viduriuojantiems k\u016bdikiams rekomenduokite t\u0119sti nat\u016bral\u0173 maitinim\u0105 kr\u016btimi. \u017dindymas palengvina ligos eig\u0105, greitina sveikim\u0105. Jei iki ligos k\u016bdikiai buvo maitinami pieno mi\u0161iniu, tai ir sirgdami tur\u0117t\u0173 gauti t\u0105 pat\u012f pieno mi\u0161in\u012f, nebent gydytojas skyr\u0117 special\u0173 mi\u0161in\u012f viduriuojan\u010diam vaikui.<\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Svarbiausia \u2013 negalima maitinti per prievart\u0105. Priminkite mamai, kad sergantis vaikas tur\u0117t\u0173 valgyti tiek, kiek jis nori, o jei yra galimyb\u0117, tai ir ma\u017eiau. <\/span><\/li>\n<\/ul>\n<ul style=\"margin-top: 0cm;\">\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Rekomenduojami speciali\u0173 drusk\u0173 mi\u0161ini\u0173 tirpalai, nes jie yra geriausia apsauga nuo skys\u010di\u0173 ir elektrolit\u0173 netekimo, pilvo p\u016btim\u0105 ma\u017einantys vaistai, probiotikai<\/span><em style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold;\">.<\/span><\/em><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Patarkite vartoti racekadotril\u012f (<em><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/-\/11217\">Hidrasec<\/a><\/em>), kuris yra skirtas vaik\u0173 nuo trij\u0173 m\u0117nesi\u0173 am\u017eiaus \u016bminio viduriavimo simptomams gydyti. \u0160\u012f vaist\u0105 reikia vartoti kartu su gausiu skys\u010di\u0173 kiekiu, taikant \u012fprastines dietos priemones, kai vien tik \u0161i\u0173 priemoni\u0173 nebepakanka veiksmingai reguliuoti viduriavimui ir \u012fprastinis gydymas n\u0117ra \u012fmanomas.<\/span><\/li>\n<\/ul>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Prie\u0161 skiriant gydym\u0105 naudinga i\u0161siai\u0161kinti ne tik tai, kokios kilm\u0117s suk\u0117l\u0117jas l\u0117m\u0117 simptom\u0173 atsiradim\u0105, bet ir kiek skys\u010di\u0173 jau yra netek\u0119s vaikas. Geriausias dehidratacijos matas yra prarasto k\u016bno svorio procentas. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Remiantis Pasaulio sveikatos organizacijos (PSO) ir Lig\u0173 kontrol\u0117s centro (LKC) rekomendacijomis, pacientai skiriami \u012f pogrupius:<\/span><\/em><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 2.0cm; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l5 level1 lfo7;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">minimalios dehidratacijos arba be dehidratacijos (netek\u0119 &lt; 3 proc. k\u016bno svorio);<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 2.0cm; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l5 level1 lfo7;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">nedidel\u0117s arba vidutin\u0117s dehidratacijos (netek\u0119 3\u20139 proc. k\u016bno svorio);<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 2.0cm; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l5 level1 lfo7;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">sunkios dehidratacijos (netek\u0119 &gt; 9 proc. k\u016bno svorio).<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold;\">Kada patarti jau kreiptis \u012f gydytojus:<\/span><\/em><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">\u2022 <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/viduriavimas-2\/72707\">viduriavimas<\/a> u\u017esit\u0119s\u0117 ilgiau nei 2 paras. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">\u2022 i\u0161matose yra kraujo, gleivi\u0173 ar kit\u0173 jums nerim\u0105 kelian\u010di\u0173 priemai\u0161\u0173. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">\u2022 temperat\u016bra pakyla daugiau nei 38<sup>o<\/sup> C. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">\u2022 atsiranda stipr\u016bs pilvo ar i\u0161ang\u0117s skausmai.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">\u2022 i\u0161sivysto dehidratacija, kurios po\u017eymiai \u2013 nenumaldomas tro\u0161kulys, burnos sausm\u0117, susirauk\u0161l\u0117jusi oda, labai suma\u017e\u0117j\u0119s \u0161lapimo kiekis;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 18.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l6 level1 lfo4; tab-stops: list 18.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">jei i\u0161kilo bet koks, t\u0117vus neraminantis simptomas.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Naujas vaistas vaik\u0173 viduriavimui gydyti<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Racekadotrilis yra enkefalinaz\u0117s inhibitorius. Enkefalinaz\u0117 dalyvauja skaidant endogeninius peptidus, tokius kaip enkefalinai. Racekadotrilis apsaugo enkefalinus nuo skaldymo fermentais, taip pailgindamas j\u0173 veikim\u0105 ties enkefalinergin\u0117mis sinaps\u0117mis plonosiose \u017earnose ir slopindamas sekreto i\u0161siskyrim\u0105.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Racekadotrilis yra gryna sekreto i\u0161siskyrim\u0105 \u017earnyne slopinanti veiklioji med\u017eiaga. Ji \u017earnyne ma\u017eina vandens ir elektrolit\u0173 hipersekrecij\u0105, bet neturi poveikio bazinei sekreto i\u0161siskyrimo veiklai. Racekadotrilis turi greit\u0105 antidiar\u0117jin\u012f poveik\u012f ir nekei\u010dia \u017earnyno tranzito trukm\u0117s.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Dviejuose klinikiniuose tyrimuose su vaikais racekadotrilis atitinkamai 40 proc. ir 46\u00a0proc. suma\u017eino i\u0161mat\u0173 mas\u0119 per pirmas 48 valandas. Be to, buvo nustatytas reik\u0161mingas viduriavimo trukm\u0117s ir rehidratacijos poreikio suma\u017e\u0117jimas (1).<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Individuali\u0173 pacient\u0173 duomen\u0173 metaanaliz\u0117 (9 atsitiktini\u0173 im\u010di\u0173 klinikiniai tyrimai, racekadotril\u012f lyginant su placebu, bei papildomai su geriamuoju rehidrataciniu tirpalu) nagrin\u0117jo duomenis, surinktus i\u0161 individuali\u0173 pacient\u0173: 1384 berniuk\u0173 ir mergai\u010di\u0173, sirgusi\u0173 \u016bmiu \u012fvairaus sunkumo viduriavimu bei gydyt\u0173 ligonin\u0117se arba ambulatori\u0161kai.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Vidutinis am\u017eius buvo 12 m\u0117nesi\u0173 (tarpkvartilinis plotis: nuo 6 iki 39 m\u0117nesi\u0173). I\u0161 viso 714 pacient\u0173 buvo &lt; 1 met\u0173, o 670 pacient\u0173 &gt; 1 met\u0173 am\u017eiaus. Vidutinis k\u016bno svoris buvo nuo 7,4 kg iki 12,2 kg visuose tyrimuose. Bendra vidutin\u0117 viduriavimo trukm\u0117 po \u012ftraukimo \u012f tyrim\u0105 buvo 2,81 dienos placebo grup\u0117je ir 1,75 dienos racekadotrilio grup\u0117je. Lyginant su placebu, pasveikusi\u0173 pacient\u0173 dalis buvo didesn\u0117 racekadotrilio grup\u0117je (rizikos santykis (RS): 2.04; 95\u00a0proc. PI: nuo 1,85 iki 2,32; p &lt; 0,001). Labai pana\u0161\u016bs gauti k\u016bdiki\u0173 rezultatai (&lt; 1 met\u0173 am\u017eiaus) (RS: 2,01; 95\u00a0proc. PI: nuo 1,71 iki 2,36; p &lt; 0.001) ir ma\u017eiems vaikams (&gt; 1 met\u0173 am\u017eiaus) (RS: 2,16; 95 proc. PI: nuo 1,83 iki 2,57; p &lt; 0,001). Tiriant hospitalizuotus pacientus (n = 637 pacientai), vidutinio i\u0161mat\u0173 i\u0161skyrimo santykis racekadotrilio\/placebo grup\u0117se buvo 0,59 (95\u00a0proc. PI: nuo 0,51 iki 0,74); p &lt; 0,001). Tiriant ambulatorinius pacientus (n = 695) vidutinio diar\u0117jini\u0173 i\u0161mat\u0173 i\u0161skyrimo santykis racekadotrilio\/placebo grup\u0117se buvo 0,63 (95\u00a0proc. PI: nuo 0,47 iki 0,85; p &lt; 0,001.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">Kitas dvigubai aklas atsitiktini\u0173 im\u010di\u0173 placebu kontroliuojamas tyrimas analizavo 72 vaikus nuo 3 m\u0117nesi\u0173 iki 4 met\u0173 am\u017eiaus, sergan\u010dius <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/roto-virusas\/72688\">rotavirusine infekcija<\/a>. Viena grup\u0117 (n = 32) gydymui vartojo <\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold;\">racekadotril\u012f, kita grupe (n = 35) gavo placeb\u0105. <span style=\"mso-bidi-font-style: italic;\">Tyrimo duomenimis, <\/span>racekadotrilio vartojusioje grup\u0117je viduriavimo trukm\u0117 suma\u017e\u0117jo nuo 36 val. iki 6,9 val. (p &lt; 0,02).<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-style: italic;\">Apibendrinimas<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">\u016aminis <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/vaiku-viduriavimas\/4438\">vaik\u0173 viduriavimas<\/a> i\u0161lieka itin svarbi problema. Gydyti vartojamiems vaistams keliami keli reikalavimai: greitai gr\u0105\u017einti pacient\u0105 \u012f normal\u0173 kasdien\u012f gyvenim\u0105, sutrumpinti viduriavimo trukm\u0119, sukeliant kuo ma\u017eiau nepageidaujam\u0173 rei\u0161kini\u0173. <\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Racekadotrilis yra naujas vaistas gydant vaik\u0173 viduriavim\u0105. \u0160\u012f vaist\u0105 reikia vartoti kartu su gausiu skys\u010di\u0173 kiekiu, taikant \u012fprastines dietos priemones, kai vien tik \u0161i\u0173 priemoni\u0173 nebepakanka veiksmingai reguliuoti viduriavimui ir \u012fprastinis gydymas n\u0117ra \u012fmanomas. Jei \u012fprastai gydyti yra \u012fmanoma, racekadotrilio galima skirti papildomam gydymui. Rekomenduojama paros doz\u0117 priklauso nuo vaiko svorio: 1,5\u00a0mg\/kg vienkartin\u0117 doz\u0117 (atitinkanti 1\u20132 paket\u0117lius) tris kartus per par\u0105 reguliariais laiko tarpais. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Vaikams nuo 3 m\u0117nesi\u0173 am\u017eiaus ir sveriantiems ma\u017eiau nei 9 kg rekomenduojama vartoti <em style=\"mso-bidi-font-style: normal;\"><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/-\/11217\">Hidrasec<\/a><\/em> 10 mg paket\u0117l\u012f 3 kartus per par\u0105, sveriantiems 9\u201313 kg \u2013 po du 10 mg paket\u0117lius 3 kartus per par\u0105. Vaikams, sveriantiems 13\u201327 kg, rekomenduojama vartoti <em style=\"mso-bidi-font-style: normal;\"><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/-\/11217\">Hidrasec<\/a><\/em> 30 mg po vien\u0105 paket\u0117l\u012f 3 kartus per par\u0105, sveriantiems daugiau kaip 27 kg \u2013 po du 30 mg paket\u0117lius 3 kartus per par\u0105. Vaikai gydomi 5 paras. Gydym\u0105 reikia t\u0119sti tol, kol vaikas du kartus i\u0161situ\u0161tina normaliai.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Taip pat yra nereceptinis <em style=\"mso-bidi-font-style: normal;\"><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/-\/11217\">Hidrasec<\/a><\/em> 100 mg N10 kapsul\u0117s suaugusiesiems, vartojama po vien\u0105 kapsul\u0119 3 kartus per par\u0105.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Pareng\u0117 gyd. R. Jasiukevi\u010di\u016bt\u0117<\/span><\/em><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">\u017durnalas Farmacija ir laikas <br \/><\/span><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p><!-- [if gte mso 9]><xml>\n <o:OfficeDocumentSettings>\n  <o:AllowPNG\/>\n  <o:TargetScreenSize>1024x768<\/o:TargetScreenSize>\n <\/o:OfficeDocumentSettings>\n<\/xml><![endif]--><\/p>\n<p style=\"text-align: justify;\"><!-- [if gte mso 9]><xml>\n <w:WordDocument>\n  <w:View>Normal<\/w:View>\n  <w:Zoom>0<\/w:Zoom>\n  <w:HyphenationZone>19<\/w:HyphenationZone>\n  <w:Compatibility>\n   <w:BreakWrappedTables\/>\n   <w:SnapToGridInCell\/>\n   <w:WrapTextWithPunct\/>\n   <w:UseAsianBreakRules\/>\n  <\/w:Compatibility>\n <\/w:WordDocument>\n<\/xml><![endif]--><!-- [if gte mso 10]>\n\n\n<style>\n \/* Style Definitions *\/\n table.MsoNormalTable\n\t{mso-style-name:\"Table Normal\";\n\tmso-tstyle-rowband-size:0;\n\tmso-tstyle-colband-size:0;\n\tmso-style-noshow:yes;\n\tmso-style-parent:\"\";\n\tmso-padding-alt:0cm 5.4pt 0cm 5.4pt;\n\tmso-para-margin:0cm;\n\tmso-para-margin-bottom:.0001pt;\n\tmso-pagination:widow-orphan;\n\tfont-size:10.0pt;\n\tfont-family:\"Times New Roman\";}\n<\/style>\n\n\n<![endif]--><span style=\"font-size: 10.0pt; line-height: 115%; font-family: Arial; mso-fareast-font-family: Calibri; mso-ansi-language: LT; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold; mso-bidi-font-style: italic;\">\u016aminis vaik\u0173 viduriavimas i\u0161lieka itin svarbi problema. Gydyti vartojamiems vaistams keliami keli reikalavimai: greitai gr\u0105\u017einti pacient\u0105 \u012f normal\u0173 kasdien\u012f gyvenim\u0105, sutrumpinti viduriavimo trukm\u0119, sukeliant kuo ma\u017eiau nepageidaujam\u0173 rei\u0161kini\u0173. <\/span><span style=\"font-size: 10.0pt; line-height: 115%; font-family: Arial; mso-fareast-font-family: Calibri; mso-ansi-language: LT; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Racekadotrilis yra naujas vaistas gydant vaik\u0173 viduriavim\u0105. \u0160\u012f vaist\u0105 reikia vartoti kartu su gausiu skys\u010di\u0173 kiekiu, taikant \u012fprastines dietos priemones, kai vien tik \u0161i\u0173 priemoni\u0173 nebepakanka veiksmingai reguliuoti viduriavimui ir \u012fprastinis gydymas n\u0117ra \u012fmanomas. <\/span><\/p>\n","protected":false},"author":1,"featured_media":8314,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27313],"tags":[24505,39,3589,7432,1174,137,52,7256,3590,9,1591,138,1246,1406,8],"site":[],"post_item_type":[27345],"class_list":["post-8313","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gydymo-naujienos","tag-proc","tag-dieta","tag-hidrasec","tag-infekcija","tag-kudikiai","tag-ligonis","tag-maistas","tag-priemones","tag-racekadotrilis","tag-sloga","tag-troskulys","tag-vaistai","tag-viduriavimas","tag-virusai","tag-virusas"],"acf":{"post_sites":false},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/8313","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/comments?post=8313"}],"version-history":[{"count":0,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/8313\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/media\/8314"}],"wp:attachment":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/media?parent=8313"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/categories?post=8313"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/tags?post=8313"},{"taxonomy":"site","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/site?post=8313"},{"taxonomy":"post_item_type","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/post_item_type?post=8313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}